Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20240630062282N1Phase 3Completed
Phase 3, open-label trial of chloral hydrate in procedural sedation and analgesia (PSA) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Effective time of the drug, Sleep duration and 6 more. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20240630062282N1.